Anthos Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Anthos Therapeutics's estimated annual revenue is currently $5.9M per year.(i)
  • Anthos Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Anthos Therapeutics has 38 Employees.(i)
  • Anthos Therapeutics grew their employee count by 9% last year.

Anthos Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Anthos Therapeutics?

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients. Anthos is a formation of Blackstone (NYSE: BX) Life Sciences and Novartis AG (NYSE: NVS), one of the worlds’ leading pharmaceutical companies. The company is led by a world-class executive team highly experienced in the successful development of therapies for cardiovascular disease.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$5.9M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M380%$10M
#2
$5.5M38-7%N/A
#3
$4.4M38N/AN/A
#4
$7.5M380%N/A
#5
$4.4M3846%N/A